Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 14/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.62 |
| ▸ | NPC1 | O15118 | 7/20 | 0.62 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | CASP6 | P55212 | 1/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.58 |
| ▸ | RELA | Q04206 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | COMT | P21964 | 2/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | METAP2 | P50579 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11808148 | 0.80 | COMT (0.61) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL7548538 | 0.80 | KDM4E (0.52) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL3711196 | 0.78 | KDM4E (0.59) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL20176005 | 0.78 | KDM4E (0.59) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL3347624 | 0.77 | KDM4E (0.57) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL20176000 | 0.77 | KDM4E (0.57) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL2938512 | 0.77 | LMNA (0.56) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL364531 | 0.77 | KDM4E (0.57) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL15007502 | 0.77 | KDM4E (0.48) | KDM4EL3MBTL1NPC1RAB9AUSP2 | |
| SCHEMBL2944756 | 0.77 | CCR1 (0.55) | KDM4EL3MBTL1NPC1RAB9AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117026486-A | Fabric with antibacterial function | 安徽三宝棉纺针织投资有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-115044291-B | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115044291-A | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-119307988-A | Antioxidant for methylsulfonic acid tinning and preparation method thereof | 宝山钢铁股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-117026486-A | Fabric with antibacterial function | 安徽三宝棉纺针织投资有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-115044291-B | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115044291-B | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115044291-A | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-115044291-A | Anticorrosive grounding material and processing technology thereof | 中造科技集团有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-2285805-B1 | ARYL-QUINOLYL COMPOUNDS AND THEIR USE | CANCER REC TECH LTD (GB) | 2014-07-23 | — | — | EP | disclosed |
| EP-2285805-B1 | ARYL-QUINOLYL COMPOUNDS AND THEIR USE | CANCER REC TECH LTD (GB) | 2014-07-23 | — | — | EP | disclosed |
| US-8383816-B2 | Aryl-quinolyl compounds and their use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2013-02-26 | — | — | US | disclosed |
| US-8383816-B2 | Aryl-quinolyl compounds and their use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2013-02-26 | — | — | US | disclosed |
| US-8383816-B2 | Aryl-quinolyl compounds and their use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2013-02-26 | — | — | US | disclosed |
| US-20110053946-A1 | Aryl-Quinolyl Compounds and Their Use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| US-20110053946-A1 | Aryl-Quinolyl Compounds and Their Use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| US-20110053946-A1 | Aryl-Quinolyl Compounds and Their Use | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| WO-2009130487-A1 | ARYL-QUINOLYL COMPOUNDS AND THEIR USE | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2009-10-29 | — | — | WO | disclosed |
| US-5382502-A | Photography, simplified synthesis | EASTMAN KODAK COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053946-A1 | Aryl-Quinolyl Compounds and Their Use | BRAF, NRAS, ARAF | KDM4E 791/4885L3MBTL1 1829/4885NPC1 3458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.